Edoxaban Intermediate: Essential for Pharmaceutical Innovation
Unlock advanced pharmaceutical development with high-purity Edoxaban intermediates, crucial for groundbreaking health solutions.
Get a Quote & SampleProduct Core Value
Intermediate of Edoxaban Tosylate Hydrate
This high-quality pharmaceutical intermediate is vital for the synthesis of Edoxaban Tosylate Hydrate, a key component in modern medicine. With purity exceeding 98% and adhering to strict GMP, ISO 9001, and FDA standards, it ensures reliability in pharmaceutical research and production.
- Discover the critical role of this Edoxaban intermediate CAS 1353893-22-7 in advancing cardiovascular treatments.
- Explore the detailed synthesis pathways of the Tert-Butyl (1R,2S,5S)-2-Amino-5-(Dimethylcarbamoyl)cyclohexylcarbamate Oxalate Hydrate, ensuring efficient API production.
- Learn about the stringent quality control measures that guarantee the high purity of this vital pharmaceutical intermediate supplier.
- Understand the chemical properties of this Edoxaban precursor, essential for robust and scalable manufacturing processes.
Key Advantages
Uncompromising Purity
Achieve superior synthesis outcomes with intermediates boasting >98% purity, a cornerstone for reliable pharmaceutical development.
Certified Quality Standards
Benefit from products manufactured under GMP, ISO 9001, and FDA guidelines, ensuring global compliance and safety.
Research & Development Focus
This chemical synthesis intermediate is tailored for scientific research and the development of new therapeutic agents.
Key Applications
Pharmaceutical Synthesis
Utilized as a critical building block in the complex synthesis of Edoxaban, enhancing treatment efficacy.
Drug Discovery
Supports innovative drug discovery processes, aiding in the development of next-generation pharmaceuticals.
Scientific Research
Essential for academic and industrial research focused on new chemical entities and biological pathways.
Health Applications
Contributes to advancements in health by providing a reliable intermediate for therapeutic compounds.